Clinical Trial
doi: 10.1097/00007890-197911000-00003.
Extended treatment with antithymocyte globulin (ATGAM) in renal allograft recipients
- PMID: 392832
- DOI: 10.1097/00007890-197911000-00003
Item in Clipboard
Clinical Trial
Extended treatment with antithymocyte globulin (ATGAM) in renal allograft recipients
Transplantation.
1979 Nov.
Abstract
Twenty renal allograft recipients were treated with antithymocyte globulin (ATGAM; ATG) for up to 16 weeks in addition to azathioprine and prednisone, while 20 controls received no ATG. The ATG group showed a lower incidence of first rejection episodes during the first month after transplantation, and also a better functional graft survival rate up to 2 years after transplantation. The results in this early ATG trial were better than those in subsequent trials which used 14-day treatment regimens. Longer treatment deserves another look.
Similar articles
-
Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen.Transplantation. 1979 Oct;28(4):294-302. doi: 10.1097/00007890-197910000-00006. Transplantation. 1979. PMID: 388762 Clinical Trial.
-
The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.Transplant Proc. 1979 Mar;11(1):27-30. Transplant Proc. 1979. PMID: 377644 Clinical Trial. No abstract available.
-
Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.Surgery. 1976 Aug;80(2):155-63. Surgery. 1976. PMID: 781887 Clinical Trial.
-
Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.Transplantation. 2001 Dec 27;72(12):1915-9. doi: 10.1097/00007890-200112270-00008. Transplantation. 2001. PMID: 11773888 Clinical Trial.
-
Muromonab-CD3 and antithymocyte globulin in renal transplantation.Ann Pharmacother. 1997 Nov;31(11):1370-7. doi: 10.1177/106002809703101115. Ann Pharmacother. 1997. PMID: 9391693 Review.
Cited by
-
Immunosuppressive therapy for renal transplantation.Springer Semin Immunopathol. 1984;7(1):43-57. doi: 10.1007/BF01891779. Springer Semin Immunopathol. 1984. PMID: 6234670 Review. No abstract available.
-
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2. Cochrane Database Syst Rev. 2017. PMID: 28073178 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources